Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Perrigo Faces $370m Tax Payment From Second IRS Audit Linked To Elan Deal

Nov 07 2019

• By Malcolm Spicer

WASHINGTON, DC - DECEMBER 26: Sign outside the Internal Revenue Service building in downtown Washington, DC on December 26, 2014.

Related Content

Irish $1.9bn Tax Bill 'Out Of Nowhere' Perplexes Perrigo, Troubles Analysts

Jan 18 2019

IRS Notice Pushes Perrigo's Potential Tax Debt From Move To Ireland Close To $3bn

Apr 30 2019

Related Companies

Perrigo Company PLC

Elan Corporation

Perrigo Company PLC

Additional Topics

International Ireland Europe United States OTC Drugs Legal Issues Advertising, Marketing & Sales Business Strategies Commercial Companies Manufacturing Consumer

More from Legal

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.